Premium
Pharmaceutical Considerations in Aerosol Drug Delivery
Author(s) -
Kuhn Robert J.
Publication year - 2002
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.22.6.80s.33907
Subject(s) - nebulizer , drug delivery , drug , aerosolization , scope (computer science) , medicine , intensive care medicine , cystic fibrosis , risk analysis (engineering) , medical physics , pharmacology , computer science , nanotechnology , materials science , inhalation , anesthesia , programming language
Aerosolized drug delivery has been used for over 50 years, but its quality and scope continue to increase. Three factors affect this form of drug delivery: the nebulizer, the compressor, and the actual drug preparation. As technology and knowledge improve, this delivery system also improves. Patients with cystic fibrosis, in particular, can benefit significantly from this form of therapy.